Nomenclature
CAS number: 53643-48-4
3-(Aminocarbonyl)-
O4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine; desacetylvinblastine amide; VDS; Compound 112531; NSC-245467.
C
43H
55N
5O
7; mol wt 753.93.
C 68.50%, H 7.35%, N 9.29%, O 14.85%.
Description and references
Synthetic deriv of the dimeric Catharanthus alkaloid vinblastine, q.v. Prepn: G. J. Cullinan, K. Gerzon, DE 2415980 (1974 to Lilly), C.A. 82, 72191r (1975); see
also C. J. Burnett et al., J. Med. Chem. 21, 88 (1978). 13C-NMR spectroscopy: D. E. Dorman, J. W. Paschal, Org. Magn. Reson. 8, 413 (1976).
Antitumor activity in rodents: M. J. Sweeney et al., Cancer Res. 38, 2886 (1978).
Pharmacokinetics: R. J. Owellen et al., ibid. 37, 2603 (1977). Use in
acute lymphocytic leukemia of childhood: W. Krivit et al., Cancer Chemother. Pharmacol. 2, 267 (1979). Brief review of preclinical and early
clinical data: R. W. Dyke et al., ibid. 229.
Toxicology: G. C. Todd et al., Toxicol. Environ. Health 1, 843 (1976); R.
J. Owellen et al., Biochem. Pharmacol. 26, 1213 (1977).
Properties
Crystals from ethanol-methanol, mp 230-232°. [α]D25 +39.4° (c = 1.0
in methanol). uv max (methanol): 214, 266, 288, 296 nm (ε 53400, 17450, 13950, 12500). pKa′ (DMF 66%) 5.39, 7.36; (H2O) 6.04, 7.67.Derivative
Sulfate salt.
Nomenclature
CAS number: 59917-39-4
LY-099094; Eldisine (Lilly); Fildesin (Shionogi).
C
43H
55N
5O
7.H
2SO
4; mol wt 852.00.
C 60.62%, H 6.74%, N 8.22%, O 20.66%, S 3.76%.
Properties
Amorphous solid from ethanol-isopropyl alcohol, mp >250° (solvated form). LD50 in mice, rats (mg/kg): 6.3 ± 0.6, 2.0 ± 0.2 i.v. (Todd);
in mice: 8.8 ± 2.5 i.p. (Owellen, Biochem. Pharmacol.).Therapeutic Category
Antineoplastic.
Keywords
Antineoplastic; Alkaloids/Natural Products; Vinca Alkaloids